NEW YORK, Dec. 18, 2018 /PRNewswire/ -- The Xiamen Encheng Group Co., Ltd., a pharmaceutical services and precision medicine-focused company located in Xiamen City, Fujian Province, China, announced today that it has entered into a strategic partnership with DarwinHealth, Inc, a New York City biotechnology company. Specifically, the Encheng Group will exclusively license the New York State Department of Health CLIA-certified DarwinOncoTarget and DarwinOncoTreat tests as part of a multi-year agreement that will grant Encheng the rights to deploy...
发布时间:
2018
-
12
-
20
浏览次数:194